Insight journal - Dealtalk, M&A

Merger & acquisition: Warner Chilcott to explore sale of company

Posted on 02 May 2012

Tags: , , ,

Specialty pharmaceutical company Warner Chilcott Plc said it would explore strategic options, including preliminary talks with potential buyers, sending its shares up as much as 24 percent to strike a potential merger & acquisition deal.

The company, which makes women's healthcare and dermatology products and other specialty drugs, said it hired Goldman Sachs as its financial adviser to lead the merger & acquisition deal.

The announcement of the potential sellout of the company in a merger & acquisition comes after speculation that Bayer AG would make a bid for the Irish drugmaker at $32 per share. Warner Chilcott declined to comment on the Bayer rumor.

Some analysts suggested that other options, such as selling certain assets or declaring a special dividend, were as likely as a sale of the company. Warner picked up potentially attractive products with its 2009 purchase of Procter & Gamble's pharmaceuticals business, including the osteoporosis drug Actonel and the ulcerative colitis drug Asacol.

Read the full story at Reuters

 

Related

Read: more on dealtalk in pharma, biotech, life science partnering deal news, insights and glossary

Report: Merger and Acquisition Terms and Agreements

View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

View: Current Partnering’s Big Biotech Deal Making Scorecard – latest trends in big biotech deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter - reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Follow us on: LinkedIn Current Partnering | LinkedIn Business Development Network | @Currentpartner on Twitter

Print Friendly, PDF & Email

Leave a Reply